Home NDC 42858-799 MS Contin
Product NDC 42858-799
11-digit product format 428580799
Labeler code 42858
Product ID 42858-799_426c7771-4aee-4e4d-b3c0-6cefb0f7e154
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name morphine sulfate
Dosage form TABLET
Route ORAL
Labeler Rhodes Pharmaceuticals L.P.
Application NDA019516
Marketing category NDA
Marketing start 2017-05-15
Marketing end 0000-00-00
Substance MORPHINE SULFATE
Active strength 100 mg/1
Pharmacologic classes Full Opioid Agonists [MoA], Opioid Agonist [EPC]
DEA schedule CII
NDC exclude flag No
Listing certified through 2023-12-31
Current FDA listing Historical FDA.report record
Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 4 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Dataset, Scope table Captured / source date Dataset Scope Package NDC Snapshot Source SHA-256 2025-04-01 02:39 UTC · source 2025-03-31 excluded product product 2ef7874e63bc…57b86245f4fa…2025-04-01 02:39 UTC · source 2025-03-31 excluded package package 42858-799-01 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 excluded product product a1b67e2a42f9…c4cf2c586c0d…2025-03-28 20:22 UTC · source 2025-03-28 excluded package package 42858-799-01 a1b67e2a42f9…c4cf2c586c0d…
Source provenance: Browse the complete Orange Book source catalog · source snapshot 45 .
Orange Book products# Current product rows page 1 of 1 · 5 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N019516-001 MS CONTIN MORPHINE SULFATE 30MG TABLET, EXTENDED RELEASE / ORAL AB RLD 1987-05-29 N019516-002 MS CONTIN MORPHINE SULFATE 60MG TABLET, EXTENDED RELEASE / ORAL AB RLD 1988-04-08 N019516-003 MS CONTIN MORPHINE SULFATE 15MG TABLET, EXTENDED RELEASE / ORAL AB RLD 1989-09-12 N019516-004 MS CONTIN MORPHINE SULFATE 100MG TABLET, EXTENDED RELEASE / ORAL RLD 1990-01-16 N019516-005 MS CONTIN MORPHINE SULFATE 200MG TABLET, EXTENDED RELEASE / ORAL RLD 1993-11-08
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 3 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 6 · 225 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-11-14 07:37:17 2026-10 N019516-001 MS CONTIN 30MG TABLET, EXTENDED RELEASE / ORAL AB RLD 1987-05-29 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N019516-002 MS CONTIN 60MG TABLET, EXTENDED RELEASE / ORAL AB RLD 1988-04-08 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N019516-003 MS CONTIN 15MG TABLET, EXTENDED RELEASE / ORAL AB RLD 1989-09-12 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N019516-004 MS CONTIN 100MG TABLET, EXTENDED RELEASE / ORAL RLD 1990-01-16 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N019516-005 MS CONTIN 200MG TABLET, EXTENDED RELEASE / ORAL RLD 1993-11-08 d4dbc9d85df4…2026-10-15 13:18:30 2026-09 N019516-001 MS CONTIN 30MG TABLET, EXTENDED RELEASE / ORAL AB RLD 1987-05-29 c2088c7a36db…2026-10-15 13:18:30 2026-09 N019516-002 MS CONTIN 60MG TABLET, EXTENDED RELEASE / ORAL AB RLD 1988-04-08 c2088c7a36db…2026-10-15 13:18:30 2026-09 N019516-003 MS CONTIN 15MG TABLET, EXTENDED RELEASE / ORAL AB RLD 1989-09-12 c2088c7a36db…2026-10-15 13:18:30 2026-09 N019516-004 MS CONTIN 100MG TABLET, EXTENDED RELEASE / ORAL RLD 1990-01-16 c2088c7a36db…2026-10-15 13:18:30 2026-09 N019516-005 MS CONTIN 200MG TABLET, EXTENDED RELEASE / ORAL RLD 1993-11-08 c2088c7a36db…2026-09-14 22:38:34 2026-08 N019516-001 MS CONTIN 30MG TABLET, EXTENDED RELEASE / ORAL AB RLD 1987-05-29 84e616aacf4f…2026-09-14 22:38:34 2026-08 N019516-002 MS CONTIN 60MG TABLET, EXTENDED RELEASE / ORAL AB RLD 1988-04-08 84e616aacf4f…2026-09-14 22:38:34 2026-08 N019516-003 MS CONTIN 15MG TABLET, EXTENDED RELEASE / ORAL AB RLD 1989-09-12 84e616aacf4f…2026-09-14 22:38:34 2026-08 N019516-004 MS CONTIN 100MG TABLET, EXTENDED RELEASE / ORAL AB RLD, RS 1990-01-16 84e616aacf4f…2026-09-14 22:38:34 2026-08 N019516-005 MS CONTIN 200MG TABLET, EXTENDED RELEASE / ORAL AB RLD 1993-11-08 84e616aacf4f…2026-08-18 06:07:40 2026-07 N019516-001 MS CONTIN 30MG TABLET, EXTENDED RELEASE / ORAL AB RLD 1987-05-29 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N019516-002 MS CONTIN 60MG TABLET, EXTENDED RELEASE / ORAL AB RLD 1988-04-08 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N019516-003 MS CONTIN 15MG TABLET, EXTENDED RELEASE / ORAL AB RLD 1989-09-12 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N019516-004 MS CONTIN 100MG TABLET, EXTENDED RELEASE / ORAL AB RLD, RS 1990-01-16 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N019516-005 MS CONTIN 200MG TABLET, EXTENDED RELEASE / ORAL AB RLD 1993-11-08 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N019516-001 MS CONTIN 30MG TABLET, EXTENDED RELEASE / ORAL AB RLD 1987-05-29 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N019516-002 MS CONTIN 60MG TABLET, EXTENDED RELEASE / ORAL AB RLD 1988-04-08 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N019516-003 MS CONTIN 15MG TABLET, EXTENDED RELEASE / ORAL AB RLD 1989-09-12 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N019516-004 MS CONTIN 100MG TABLET, EXTENDED RELEASE / ORAL AB RLD, RS 1990-01-16 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N019516-005 MS CONTIN 200MG TABLET, EXTENDED RELEASE / ORAL AB RLD 1993-11-08 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N019516-001 MS CONTIN 30MG TABLET, EXTENDED RELEASE / ORAL AB RLD 1987-05-29 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N019516-002 MS CONTIN 60MG TABLET, EXTENDED RELEASE / ORAL AB RLD 1988-04-08 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N019516-003 MS CONTIN 15MG TABLET, EXTENDED RELEASE / ORAL AB RLD 1989-09-12 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N019516-004 MS CONTIN 100MG TABLET, EXTENDED RELEASE / ORAL AB RLD, RS 1990-01-16 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N019516-005 MS CONTIN 200MG TABLET, EXTENDED RELEASE / ORAL AB RLD 1993-11-08 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N019516-001 MS CONTIN 30MG TABLET, EXTENDED RELEASE / ORAL AB RLD 1987-05-29 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N019516-002 MS CONTIN 60MG TABLET, EXTENDED RELEASE / ORAL AB RLD 1988-04-08 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N019516-003 MS CONTIN 15MG TABLET, EXTENDED RELEASE / ORAL AB RLD 1989-09-12 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N019516-004 MS CONTIN 100MG TABLET, EXTENDED RELEASE / ORAL AB RLD, RS 1990-01-16 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N019516-005 MS CONTIN 200MG TABLET, EXTENDED RELEASE / ORAL AB RLD 1993-11-08 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N019516-001 MS CONTIN 30MG TABLET, EXTENDED RELEASE / ORAL AB RLD 1987-05-29 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N019516-002 MS CONTIN 60MG TABLET, EXTENDED RELEASE / ORAL AB RLD 1988-04-08 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N019516-003 MS CONTIN 15MG TABLET, EXTENDED RELEASE / ORAL AB RLD 1989-09-12 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N019516-004 MS CONTIN 100MG TABLET, EXTENDED RELEASE / ORAL AB RLD, RS 1990-01-16 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N019516-005 MS CONTIN 200MG TABLET, EXTENDED RELEASE / ORAL AB RLD 1993-11-08 fd3edfee7708…
Observed Orange Book normalized TE history# Normalized TE history page 3 of 6 · 221 observed states.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 42858-799-01 MS Contin 100 in 1 BOTTLE, PLASTIC TABLET 100 16
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 42858-799 MS CONTIN (MORPHINE SULFATE) TABLET [RHODES PHARMACEUTICALS L.P.] 13 Legacy NDC, 1 package rows 20250410_c354b3bf-86c0-4bb8-8b1f-be2164942698.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join MS Contin MORPHINE SULFATE Rhodes Pharmaceuticals LLC c354b3bf-86c0-4bb8-8b1f-be2164942698 2026-08-14 Boxed warning, Warnings, Adverse reactions Exact identifier application applno (NDA): 019516 application number: NDA019516
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 42858-799-01 42858079901 100 TABLET in 1 BOTTLE, PLASTIC (42858-799-01) 100 tablet 2017-05-15 0000-00-00 No No Current 42858-799-50 42858079950 500 TABLET in 1 BOTTLE, PLASTIC (42858-799-50) 500 tablet 2017-05-15 0000-00-00 No No Current